Evidence map›Paper›PMID 39925489›Full record

ArticleCureus2025

A Case of Interstitial Pneumonia Leading to Respiratory Failure Several Months After COVID-19 Infection.

Katsuro Kashima, Hiromi Matsuyama, Yusuke Yoshishige, Shouta Nakazono

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katsuro KashimaCardiology, Ibusuki Medical Center, Ibusuki, JPN.
Hiromi MatsuyamaPulmonary Medicine, Kagoshima University, Kagoshima, JPN.
Yusuke YoshishigeCardiology, Ibusuki Medical Center, Ibusuki, JPN.
Shouta NakazonoCardiology, Ibusuki Medical Center, Ibusuki, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While acute pneumonia is commonly observed in the early stages of coronavirus disease 2019 (COVID-19) infection, isolated cases of interstitial pneumonia have been reported several months later. In this case, interstitial lung disease was identified on a routine follow-up examination five months after infection. Eight months after infection, the patient developed worsening interstitial lung disease, pulmonary hypertension, and worsening symptoms, leading to respiratory failure. Careful follow-up is necessary for patients with COVID-19 who experience progressive pulmonary lesions.

Indexed as

diffuse alveolar damageinterstitial lung disease causepost-covid-19 complicationspulmonary bullapulmonary hypertension

Identifiers

PMID39925489
PMCPMC11805603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.